Brilacidin
Clinical data | |
---|---|
Trade names | None as of July 2012[1] |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C40H50F6N14O6 |
Molar mass | 936.9 g/mol g·mol−1 |
3D model (JSmol) | |
| |
|
Brilacidin (formerly PMX-30063) is an antibiotic peptide that works by disrupting bacterial cell membranes.[2]
Notes
- ^ a b "STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL" (Document). American Medical Association. July 25, 2012.
{{cite document}}
: Unknown parameter|url=
ignored (help) - ^ "brilacidin (formerly PMX-30063)". BioCentury BCIQ. BioCentury Publications. Retrieved 2013-09-19.
References
- "PolyMedix Receives USAN Approval for Generic Name of Brilacidin for PMX-30063". Globe NewsWire. June 12, 2012. Retrieved 2013-09-19.